Chapel Hill, NC, United States of America

Xin Ming

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):

Title: Innovations of Inventor Xin Ming

Introduction

Xin Ming is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of nucleic acid delivery, holding 2 patents that focus on enhancing the activity of oligonucleotides. Her work is particularly relevant for medical applications, including treatments for disorders such as cystic fibrosis.

Latest Patents

One of her latest patents is titled "Benzimidazoles that enhance the activity of oligonucleotides." This disclosure outlines methods, compounds, and compositions for delivering nucleic acids to specific cells. It emphasizes the effectiveness of certain salts in delivering nucleic acids to lung cells, which is crucial for treating conditions like cystic fibrosis. Another significant patent is "Small molecules that enhance the activity of oligonucleotides." This patent describes methods for administering oligonucleotides into cells, both in vitro and in vivo, using small organic compounds to improve delivery and activity.

Career Highlights

Xin Ming has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and Southern Research Institute. Her research has contributed to advancements in the field of molecular biology and therapeutic development.

Collaborations

Some of her notable coworkers include Rudolph L. Juliano and William Perry Janzen. Their collaborative efforts have furthered the understanding and application of oligonucleotide technologies.

Conclusion

Xin Ming's innovative work in enhancing oligonucleotide activity has the potential to significantly impact medical treatments, particularly for genetic disorders. Her contributions to the field are invaluable and continue to inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…